Health & Safety Industry Today

Next Generation Sequencing Market, By Application, Analysis and Outlook to 2022 published “Next Generation Sequencing Market” from its database. This report Strategic recommendations in key business segments based on the market estimations. This report Supply chain trends mapping the latest technological advancements.
Published 25 January 2018
According to Publisher, the Global Next Generation Sequencing market is estimated at $3.41 billion in 2015 and is expected to reach $13.50 billion by 2022 growing at a CAGR of 21.73% from 2015 to 2022. The growing adoption of sequencing technologies in clinical applications and low cost DNA sequencing are likely to drive the market growth. However, factors such as accuracy and standardization issues and lack of skilled labor are inhibiting the market growth. The rise in personalize medicine and cloud computing are likely to create more opportunities for this market during the forecast period.
For more information at
In technology, sequencing by synthesis (SBS) segment is anticipated to move with a highest CAGR during forecast period. Diagnostics in application segment holds the largest share and is expected to grow at highest CAGR during forecast period. Research institutions held the largest market share in end user segment. North America dominates the global next generation sequencing market followed by Europe owing to rising government support towards research and development. Asia pacific is expected to grow at a faster rate during the forecast period due to the unmet market demand and increasing investments for development of healthcare.

Some of the key players in the market include Roche Holding Ag, Qiagen N.V., Knome, Inc., Perkinelmer, Inc., Partek, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd., Macrogen Inc., Life Technologies Corporation, Illumina, Inc., Genomatix Software GmbH, GATC Biotech Ag., Eurofins Scientific, DNASTAR Inc., Biomatters, Ltd., Beijing Genomics Institute and Agilent Technologies, Inc.

Platforms Covered:
- Sequencing Services
o Exome Sequencing
o Methyl- Sequencing 
o Targeted Re-Sequencing
o Whole-Genome Sequencing
o De Novo Sequencing
o Chip- Sequencing 
o RNA- Sequencing 
o Other Sequencing Services
- Sequencing Platforms
o Thermo Fisher Scientific (Life Technologies)
- ION S5 & S5 Xl
- ION Proton
o Pacific Biosciences
o Illumina
o Other Sequencing Platforms

Technologies Covered:
- Sequencing By Ligation (SBL)
- Single-Molecule Real-Time Sequencing (SMRT)
- Sequencing By Synthesis (SBS)
- Pyrosequencing
- ION Semiconductor Sequencing
- Other Technologies

End Users Covered:
- Hospitals and clinics
- Biotech & Pharma Firms
- Research institutions
- Other End Users

Applications Covered:
- Personalized medicines
- Drug Discovery
- Diagnostics
- Agriculture & Animal Research
- Prenatal Testing
- Biomarker Discovery
- HLA Testing
- Infectious Diseases
- Genetic Screening
- Oncology
- Idiopathic Diseases
- Other Applications
Request Sample Copy: .
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK 
o Spain 
o Rest of Europe 
- Asia Pacific
o Japan 
o China 
o India 
o Australia 
o New Zealand 
o Rest of Asia Pacific 
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
11 Company Profiling 
11.1 Roche Holding Ag 
11.2 Qiagen N.V. 
11.3 Knome, Inc. 
11.4 Perkinelmer, Inc. 
11.5 Partek, Inc. 
11.6 Pacific Biosciences 
11.7 Oxford Nanopore Technologies, Ltd. 
11.8 Macrogen Inc. 
11.9 Life Technologies Corporation 
11.10 Illumina, Inc. 
11.11 Genomatix Software GmbH 
11.12 GATC Biotech Ag. 
11.13 Eurofins Scientific 
11.14 DNASTAR Inc. 
11.15 Biomatters, Ltd. 
11.16 Beijing Genomics Institute 
11.17 Agilent Technologies, Inc. 
Buy Now:
Contact Us:
Call: +1-646-491-9876

Other Industry News

Ready to start publishing

Sign Up today!